Of the people, by the people, for the people
How the narrative about what Twitter cost Elon Musk is obscuring what it’s worth.
Sam Bankman-Fried and our enduring faith in the tech whiz kid
Even the collapse of FTX probably won't kill the archetype.
The last days of the war on drugs
Prohibition is slowly coming to an end as jurisdictions around the world liberalise drug laws.
Tech lay-offs teach us a lesson about the ‘war for talent’
Benevolent workplace dictatorships can seem fine until they’re not so benevolent any more.
Psychedelics and business could make for a bad trip
Brash new investors are clashing with the pioneers of mind-altering drug therapies.
The lingering tragedy of Japan’s ‘lost generation’
Japan can't summon the will to confront the problems of its economic underclass.
My sad, lonely, expensive adventures in Zuckerberg’s VR
Meta is spending billions on virtual reality, but has very little to show for it.
In the political talk show race, outrage is winning
Outrage makes more money, and today’s conservative media is veritable gold mine.